The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of durvalumab plus tremelimumab for unresectable hepatocellular carcinoma in Thailand: A real-world multicenter observational study.
 
Krittiya Korphaisarn
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; MSD Oncology; Takeda
Speakers' Bureau - Amgen; AstraZeneca; MSD Oncology; Roche; Takeda
Research Funding - AstraZeneca (Inst); BeiGene (Inst); MSD Oncology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Eisai; MSD Oncology; Roche; Zuellig Pharma
 
Kosin Wirasorn
No Relationships to Disclose
 
Suebpong Tanasanvimon
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb/Celgene; Eisai; Ipsen; Lilly; Merck; MSD; Novartis; Roche Canada
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; Eisai; Merck; MSD
Travel, Accommodations, Expenses - Eisai; MSD Oncology; Roche
 
Kijjakom Thanasombunsukh
No Relationships to Disclose
 
Kunlatida Maneenil
No Relationships to Disclose
 
Jirawat Thanestada
No Relationships to Disclose
 
Nattaya Teeyapun
No Relationships to Disclose
 
Jarin Chindaprasirt
No Relationships to Disclose
 
Chirawadee Sathitruangsak
No Relationships to Disclose
 
Teerada Siripoon
No Relationships to Disclose
 
Phannin Tiraswasdichai
No Relationships to Disclose
 
Chanchai Charonpongsuntorn
Research Funding - AstraZeneca; BeiGene
 
Passakorn Wanchaijiraboon
No Relationships to Disclose
 
Wannisa Laosuangkoon
No Relationships to Disclose
 
Patrapim Sunpaweravong
Honoraria - Amgen; AstraZeneca; BMS; Daiichi Sankyo; DKSH; Eisai; Janssen; Juniper Biologics; MSD; Novartis; Roche; Taiho Pharmaceutical; ZP Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Daiichi Sankyo; Eisai; Janssen; MSD; Novartis; Roche; ZP Therapeutics
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Exscientia (Inst); Janssen (Inst); Mirati Therapeutics (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; BMS; DKSH; Eisai; Janssen; Juniper Biologics; MSD; Novartis; Pfizer; Roche; Taiho Pharmaceutical; Zuellig Pharma
 
Charuwan Akewanlop
Speakers' Bureau - Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca/MedImmune; Roche
 
TSCO GI groups
No Relationships to Disclose